Lactiga Forges NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment

Press/Media

Period14 Oct 2020 → 15 Oct 2020

Media coverage

3

Media coverage

  • TitleLactiga Forges NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment
    Media name/outletM2Pharma.com
    Country/TerritoryUnited States
    Date15/10/20
    URLm2pharma.com/news/policy-and-regulations/article.php?id=87861
    PersonsRebecca Powell
  • TitleLactiga Forges NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment
    Media name/outletCorporate IT Update
    Country/TerritoryUnited States
    Date14/10/20
    PersonsRebecca Powell
  • TitleLactiga Forges NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment
    Media name/outletM2 Pharma
    Country/TerritoryUnited States
    Date14/10/20
    PersonsRebecca Powell